Abstract
The syntheses of new sulphonamide derivatives of 8,10-diazabenzo[a]phenoxazones are reported. The condensation of 4,5-diamino-6-hydroxy-2-mercaptopyrimidine and 2,3-dichloro-1,4-naphthoquinone in a basic medium gave the key functional intermediate, 11-amino-6-chloro-9-mercapto-8,10-diazabenzo[a]phenoxazin-5-one. The conversion of the later compound to its sulphonamide derivatives was achieved via nickel catalyzed cross-coupling Buchwald-Hartwig protocol. Reaction between 11-amino-6-chloro-9-mercapto-8,10-diazabenzo[a]phenoxazin-5-one and various aryl sulphonamides and sulphonyl chlorides furnished eight new mono sulphonamide substituted diazaphenoxazone compounds. Subsequent coupling of mono sulphonamide substituted diazaphenoxazone compounds 5a-d with four different arylsulphonyl chlorides under similar reaction conditions gave the disubstituted derivatives 8a-d. The products were isolated in 74 – 88% yields and characterized by means of Uv-visible, FT-IR, 1H-NMR, 13C-NMR, and Mass spectroscopy. The synthesized compounds were screened for antimicrobial activity against bacterial strains: Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Salmonella typhi and Klebsiella pneumonia, and fungal strains, Aspergillus niger, and Candida albican, using agar-well diffusion method. The activities of the compounds were compared with that of colymycin, which is a strong antibacterial, and antifungal drug, Most of the compounds showed appreciable antimicrobial activities comparable with the activity of colymycin. The in silico study revealed that all the synthesized compounds showed significant binding affinity for both intact and mutated DNA gyrase. Compounds 8a and 5b showed the highest binding affinities of -12.31 and -13.30 kcal/mol for intact and mutated DNA gyrase respectively.
Similar content being viewed by others
References
Aarestrup FM (2009) Occurrence of glycopeptides resistance among enterococcus faecium isolates from conventional and ecological poultry farms. Micro Drug Resist 1(3):255. https://doi.org/10.1089/mdr.1995.1.255
Adeniyi BA, Odelola HA (1996) Antimicrobial potentials of diospyros mespiliforrmis (Ebenaceae). Afr J Med Sci 255:211–224
Alovero F, Nieto M, Mazzieri MR, Then R, Manzo RH (1998) Mode of Action of Sulfanilyl Fluoroquinolones. Antimicrob Agents Chemother 42(6):1495–1498
Alqasoumi SI, Al-Taweel AM, Alafeefy AM, Noaman E, Ghorab MM (2010) Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents. Eur J Med Chem 45(5):1849–1853
Barness EC, Bezerra-Gomez P, Nett M, Dandamycin HC, Chandrananimycin E (2015) benzoxazines from streptomycesgriseus. J Antibiot 68:463
Bates AD, Maxwell A (2005) DNA Topology. Oxford University Press, Oxford
Boothroyd B, Clark ER (1952) Aminophenoxazines as possible antitubercular agents. J. Chem. Soc. 1499
Chen Z, Xu W, Liu K, Yang S, Fan H, Bhadury PS, Zhang DY (2010) Synthesis and antiviral activity of 5-(4-chlorophenyl)-1,3,4-thiadiazole sulfonamides. Molecules 9 15(12):9046–9056
Chu Daniel TUS (1986) Pyrido[3,2,1-k]phenoxazines and antibacterial use. Chem Abstr 104:109663k
Chu DTW, Maleczka RE (1987) Synthesis of 4-oxo-4H–quino[2,3,4-i,j][1,4]-benoxazine-5-carboxylic acid derivatives. J Heterocycl Chem 24:453–456
Eshghi H, Rahimizadeh M, Zokaei M, Eshghi S, Faghihi Z, Tabasi E, Kihanya M (2011) Synthesis and antimicrobial activity of some new macrocyclic bis-sulphonamides and disulphides. Eur Jour Chem 2(1):47–50
Gross CH, Parsons JD, Grossman TH, Charifson PS, Bellon S, Jernee J, Dwyer M, Chambers SP, Markland W, Botfield M, Scott A, Raybuck (2003) Active-site residues of Escherichia coli DNA Gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to Novobiocin resistance. Antimicrob Agents Chemother 47(3):1037–1046. https://doi.org/10.1128/AAC.47.3.1037-1046.2003
Harton JK, Thimmaiah KN, Harwood FC, Kuttesch JF, Houghton PJ (1993) Pharmacological characterization of n-substituted phenoxazines directed towards reversing vinca alkaloids resistance in multi drug resistant cancer cells. Mol. Pharmocol. Abstra 44:552–559
Hooper DC (1998) Structure of grepafloxacin relative to activity and safety profile. Clinical Microbiology and Infection 4(1):515–520. https://doi.org/10.1111/j.1469-0691.1998.tb00684.x
Ibeanu FN, Onoabedje EA, Ibezim A, Okoro UC (2018) Synthesis, characterization, computational and biological study of novel azabenzo[a]phenothiazine and azabenzo[b]phenoxazine heterocycles as potential antibiotic agent. Med Chem Res. https://doi.org/10.1007/s00044-017-2131-3
Lopez M, Drillaud N, Bornaghi LF, Pouslen SA (2009) Synthesis of s-glycosyl primary sulphonamides. J Org Chem 74(7):2811–2816
Marble A (1971) Glibenclamide, a new sulphonylurea: wither oral hypoglycaemic agents? Drugs 1(2):109–115
Maxwell A (1997) DNA gyrase as a drug target. Trends Microbiol 5:102–109
Miller LH, Baruch DI, Marsh K, Doumbo OK (2002) The pathogenic basis of malaria. Nature 7 415(6872):673–679
Okafor CO (1986) Synthesis, properties and uses of angular phenoxazines. Dyes Pigments l7(2):103–131
Okorie VC (2005) Principles of the pharmaceutical application of antimicrobial agents. Denmak Publishers, Enugu, Nigeria, p 45–47
Onoabedje EA, Okoro UC, Sarkar A, Knight DW (2016) Functionalization of linear and angular phenothiazine and phenoxazine ring systems via Pd(0)Xphos mediated Suzuki-Miyaura cross-coupling reactions. J Heterocycl Chem 53(6):1787–1794
Onoabedje EA, Okoro UC, Sarkar A, Knight DW (2016) Synthesis and structure of new alkynyl derivatives of phenothiazine and phenoxazine. J Sulfur Chem 37(3):269–281. 10. 1080/17415993, 2015.1131827
Ozbek N, Katircioglu H, Karacan N, Baykal T (2007) Synthesis, characterization and antimicrobial activity of new aliphatic sulphonamides. Bioorg & Med Chem 15(15):5105–5109
Rádl S, Zikán V (1989) Synthesis and antimicrobial activity of some 3-oxo-3H–pyrido[3,2,1-kl]phenoxazine-2-carboxylic acids. Collect Czech Chem Commun 54:506–515
Rostom SAF (2006) Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulphonamide, sulfonylurea(-thiourea)pharmacophores, and some derived thiazole ring systems. Bioorg Med Chem 14(19):6475–6485
Scozzafava A, Owa T, Mastrolorenzo A, Supuran CT (2003) Anticancer and antiviral sulphonamides. Curr Med Chem 10(11):925–953
Setter SM, Iltz JL, Fincham JE, Cambell RK, Baker DE (2005) Phosphodiesterase 5 inhibitors for erectile dysfunction (2005). Ann Pharmacother 39(7-8):1286–1295
Shen CH, Wang YF, Kovalevsky AY, Harrison RW, Weber IT (2010) Amprenavir complexes with hiv-1 protease and its drug-resistant mutants altering hydrophobic clusters. FEBS J 277(18):3699–3714
Shimamoto T, Tomada A, Ishida R, Ohyashiki K (2001) Antitumor effects of a novel phenoxazine derivatives on human leukaemia cells (AACR). Ame-Asso. for. Cancer Res 7:704–708
Threlfall EJ, Ward LR, Skinner JA, Rowe B (2009) Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: A comparison of Data for 1994 and 1996. Microb Drug Resist 3(3):263. https://doi.org/10.1089/mdr.1997.3.263
Ueda Y, Takahashi Y, Yamashita H, Kaneko H, Mimori A (2011) genetic heterogeneity of hepatitis c virus in association with antiviral therapy determined by ultra-deep sequencing. Nihon Rinsho Meneki Gakkai Kaishi 6(9):24907
Ugwu DI, Okoro UC, Chukwurah TD (2014) Nickel catalyzed synthesis of n-aryl and n-heteroaryl substituted benzene sulphonamides and their biological activity evaluation. Med Chem 4:357–360. 10417212151-0444.1000165
Vardayan RS, Hruby VJ (2006) Synthesis of essential drugs. Elsevier, Amsterdum, 499
Veber DF, Stephen RJ, Hung-Yuan C, Brian RS, Keith WW, Kenneth DK (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45(12):2615–2623. https://doi.org/10.1021/jm020017n)
Venanzi LM (1958) Tetrahedral nickel (II) complexes and the factors determining their formation, part I. Bistriphenylphosphine nickel (II) compounds. J. Chem. Soc. 719-724
Wang JC (2009) A journey in the world of DNA rings and beyond. Annu Rev Biochem 78:31–54. https://doi.org/10.1146/annurev.biochem.78.030107.090101
Wang Q, Zhang YX, Wang M, Tan Y, Hu X, He H, Xiao C, You X, Wang Y, Gan M (2017) Neo-actinomycins A and B, natural antinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from marine derived Streptomyces species IMBO94. Sci Rep 7:3591. https://doi.org/10.1038/s41598-017-03769-8
Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Kiebe G (2004) Unexpected nanomolar inhibition of carbonic anhydrase by COx-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J Med Chem 47(3):550–557
Yu X, Zhang M, Annamalai A, Bansod P, Narula G, Tse-Dinh -C, Sun D (2017) Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors. Eur J Med Chem 125:515–527. https://doi.org/10.1016/j.ejmech.2016.09.053
Zimmerman S, Innocenti A, Casini A, Ferry JG, Scozzafava A, Supuran CT (2004) Carbonic anhydrase inhibitors. Inhibition of the prokaryotic beta and gamma-class enzymes from archaea with sulfonamides. Bioorg & Med Chem Lett 14:6001–6006
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ezeokonkwo, M.A., Eze, C.C., Okafor, S.N. et al. Diazabenzo[a]phenoxazone sulphonamides: synthesis, in-silico and in-vitro antimicrobial studies. Med Chem Res 27, 2482–2493 (2018). https://doi.org/10.1007/s00044-018-2251-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-018-2251-4